LSI USA '23 filling fast. Register Now

BioAssets Development Corporation (aka BDC) (Acquired)

Tumor necrosis factor alpha (TNF-a) inhibitor therapy for treatment of chronic persistent radiculopathy (including sciatica) related to disc herniatio...

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of BioAssets Development Corporation (aka BDC) (Acquired) plus 5337 other startups.

Start Free 7 Day Trial Now

Learn More About BioAssets Development Corporation (aka BDC) (Acquired)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More

Our Clients